DISTINCT BIOMARKERS ENRICH FOR CLINICAL RESPONSE TO TOCILIZUMAB (TCZ) AND ADALIMUMAB (ADA) IN ADACTA: A HEAD-TO-HEAD MONOTHERAPY STUDY IN PATIENTS (PTS) WITH METHOTREXATE (MTX)-IR RHEUMATOID ARTHRITIS (RA)

被引：0
|
作者：
Herman, A. [1 ]
Musselman, D. [1 ]
Fischer, S. [1 ]
Setiadi, A. [1 ]
Gabay, C. [2 ]
Kavanaugh, A. [3 ]
Klearman, M. [1 ]
Song, A. [1 ]
Townsend, M. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] U Hosp Geneva, Geneva, Switzerland
[3] U Calif, San Diego, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：206 / 206
页数：1
相关论文
共 25 条
  • [21] Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
    Sakai, Ryoko
    Cho, Soo-Kyung
    Nanki, Toshihiro
    Watanabe, Kaori
    Yamazaki, Hayato
    Tanaka, Michi
    Koike, Ryuji
    Tanaka, Yoshiya
    Saito, Kazuyoshi
    Hirata, Shintaro
    Amano, Koichi
    Nagasawa, Hayato
    Sumida, Takayuki
    Hayashi, Taichi
    Sugihara, Takahiko
    Dobashi, Hiroaki
    Yasuda, Shinsuke
    Sawada, Tetsuji
    Ezawa, Kazuhiko
    Ueda, Atsuhisa
    Fujii, Takao
    Migita, Kiyoshi
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    [J]. ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [22] Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
    Ryoko Sakai
    Soo-Kyung Cho
    Toshihiro Nanki
    Kaori Watanabe
    Hayato Yamazaki
    Michi Tanaka
    Ryuji Koike
    Yoshiya Tanaka
    Kazuyoshi Saito
    Shintaro Hirata
    Koichi Amano
    Hayato Nagasawa
    Takayuki Sumida
    Taichi Hayashi
    Takahiko Sugihara
    Hiroaki Dobashi
    Shinsuke Yasuda
    Tetsuji Sawada
    Kazuhiko Ezawa
    Atsuhisa Ueda
    Takao Fujii
    Kiyoshi Migita
    Nobuyuki Miyasaka
    Masayoshi Harigai
    [J]. Arthritis Research & Therapy, 17
  • [23] Radiographic progression is inhibited in patients (pts) with long-standing rheumatoid arthritis (RA) treated with adalimumab (ADA) plus methotrexate (MTX) for 5 years (yrs) V. 1_1 to XR
    Keystone, Edward C.
    Kavanaugh, Arthur F.
    Sharp, John T.
    Patra, Kaushik
    Perez, John L.
    [J]. RHEUMATOLOGY, 2008, 47 : II47 - II47
  • [24] CLINICAL OUTCOMES OF METHOTREXATE (MTX)-NAIVE RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS) ON FILGOTINIB (FIL) LONG-TERM EXTENSION (LTE) TRIAL INITIALLY ON FIL OR MTX DURING THE PHASE 3 PARENT STUDY (PS)
    Aletaha, D.
    Westhovens, R.
    Atsumi, T.
    Tan, Y.
    Pechonkina, A.
    Gong, Q.
    Rajendran, V.
    Strengholt, S.
    Burmester, G. R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 614 - 615
  • [25] A CLINICAL STUDY TO INVESTIGATE PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD), EFFICACY, AND SAFETY OF TOCILIZUMAB (TCZ) AFTER SUBCUTANEOUS (SC) ADMINISTRATION WEEKLY (QW) OR EVERY TWO WEEKS (Q2W) IN PATIENTS (pts) WITH RHEUMATOID ARTHRITIS (RA).
    Zhang, X.
    Chen, Y.
    Fettner, S.
    Anzures-Cabrera, J.
    Gott, T.
    Grimsey, P.
    Unsworth, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S117 - S117
123